annual cash & cash equivalents:
$144.86M-$76.26M(-34.49%)Summary
- As of today (May 20, 2025), ANIP annual cash & cash equivalents is $144.86 million, with the most recent change of -$76.26 million (-34.49%) on December 31, 2024.
- During the last 3 years, ANIP annual cash & cash equivalents has risen by +$44.56 million (+44.43%).
- ANIP annual cash & cash equivalents is now -34.49% below its all-time high of $221.12 million, reached on December 31, 2023.
Performance
ANIP Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$149.80M+$4.94M(+3.41%)Summary
- As of today (May 20, 2025), ANIP quarterly cash & cash equivalents is $149.80 million, with the most recent change of +$4.94 million (+3.41%) on March 31, 2025.
- Over the past year, ANIP quarterly cash & cash equivalents has dropped by -$78.80 million (-34.47%).
- ANIP quarterly cash & cash equivalents is now -37.61% below its all-time high of $240.11 million, reached on June 30, 2024.
Performance
ANIP quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ANIP Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.5% | -34.5% |
| 3 y3 years | +44.4% | +94.8% |
| 5 y5 years | +132.4% | +633.8% |
ANIP Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -34.5% | +200.4% | -37.6% | +210.6% |
| 5 y | 5-year | -34.5% | +1742.1% | -37.6% | +1804.9% |
| alltime | all time | -34.5% | >+9999.0% | -37.6% | >+9999.0% |
ANIP Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $149.80M(+3.4%) |
| Dec 2024 | $144.86M(-34.5%) | $144.86M(-0.1%) |
| Sep 2024 | - | $144.98M(-39.6%) |
| Jun 2024 | - | $240.11M(+5.0%) |
| Mar 2024 | - | $228.60M(+3.4%) |
| Dec 2023 | $221.12M(+358.5%) | $221.12M(+14.5%) |
| Sep 2023 | - | $193.08M(+19.4%) |
| Jun 2023 | - | $161.71M(+138.7%) |
| Mar 2023 | - | $67.76M(+40.5%) |
| Dec 2022 | $48.23M(-51.9%) | $48.23M(-14.3%) |
| Sep 2022 | - | $56.28M(-11.2%) |
| Jun 2022 | - | $63.38M(-17.6%) |
| Mar 2022 | - | $76.91M(-23.3%) |
| Dec 2021 | $100.30M(+1175.4%) | $100.30M(+557.5%) |
| Sep 2021 | - | $15.25M(-37.1%) |
| Jun 2021 | - | $24.26M(-3.2%) |
| Mar 2021 | - | $25.07M(+218.8%) |
| Dec 2020 | $7.86M(-87.4%) | $7.86M(-56.1%) |
| Sep 2020 | - | $17.90M(-35.4%) |
| Jun 2020 | - | $27.70M(+35.7%) |
| Mar 2020 | - | $20.41M(-67.2%) |
| Dec 2019 | $62.33M(+44.9%) | $62.33M(+4.5%) |
| Sep 2019 | - | $59.67M(+47.0%) |
| Jun 2019 | - | $40.59M(+6.2%) |
| Mar 2019 | - | $38.23M(-11.1%) |
| Dec 2018 | $43.01M(+38.1%) | $43.01M(-2.6%) |
| Sep 2018 | - | $44.14M(-19.7%) |
| Jun 2018 | - | $54.99M(+5.8%) |
| Mar 2018 | - | $51.97M(+66.9%) |
| Dec 2017 | $31.14M(+13.8%) | $31.14M(+72.7%) |
| Sep 2017 | - | $18.03M(+115.4%) |
| Jun 2017 | - | $8.37M(-22.7%) |
| Mar 2017 | - | $10.83M(-60.4%) |
| Dec 2016 | $27.36M(-82.3%) | $27.36M(+69.4%) |
| Sep 2016 | - | $16.16M(+7.6%) |
| Jun 2016 | - | $15.01M(-80.7%) |
| Mar 2016 | - | $77.75M(-49.7%) |
| Dec 2015 | $154.68M(-8.5%) | $154.68M(+2.5%) |
| Sep 2015 | - | $150.91M(-9.5%) |
| Jun 2015 | - | $166.73M(+0.7%) |
| Mar 2015 | - | $165.56M(-2.1%) |
| Dec 2014 | $169.04M(+1422.2%) | $169.04M(+382.3%) |
| Sep 2014 | - | $35.05M(-33.8%) |
| Jun 2014 | - | $52.96M(+3.1%) |
| Mar 2014 | - | $51.37M(+362.6%) |
| Dec 2013 | $11.11M(-68.1%) | $11.11M(+1.6%) |
| Sep 2013 | - | $10.93M(-13.2%) |
| Jun 2013 | - | $12.59M(-57.1%) |
| Mar 2013 | - | $29.39M(-15.5%) |
| Dec 2012 | $34.79M | $34.79M(-8.6%) |
| Sep 2012 | - | $38.05M(-10.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $42.42M(-14.3%) |
| Mar 2012 | - | $49.47M(-13.5%) |
| Dec 2011 | $57.23M(+50.0%) | $57.23M(-17.8%) |
| Sep 2011 | - | $69.60M(+87.5%) |
| Jun 2011 | - | $37.13M(-27.7%) |
| Mar 2011 | - | $51.35M(+34.6%) |
| Dec 2010 | $38.16M(+27.8%) | $38.16M(+7.4%) |
| Sep 2010 | - | $35.53M(-23.4%) |
| Jun 2010 | - | $46.38M(+12.7%) |
| Mar 2010 | - | $41.16M(+37.9%) |
| Dec 2009 | $29.86M(+153.9%) | $29.86M(+126.7%) |
| Sep 2009 | - | $13.17M(+120.0%) |
| Jun 2009 | - | $5.99M(-41.1%) |
| Mar 2009 | - | $10.16M(-13.6%) |
| Dec 2008 | $11.76M(-24.8%) | $11.76M(+106.3%) |
| Sep 2008 | - | $5.70M(-44.8%) |
| Jun 2008 | - | $10.33M(-21.2%) |
| Mar 2008 | - | $13.11M(-16.2%) |
| Dec 2007 | $15.65M(+104.5%) | $15.65M(-38.4%) |
| Sep 2007 | - | $25.40M(-7.2%) |
| Jun 2007 | - | $27.38M(+142.5%) |
| Mar 2007 | - | $11.29M(+47.5%) |
| Dec 2006 | $7.65M(+2364.2%) | $7.65M(+1990.1%) |
| Sep 2006 | - | $366.20K(+174.1%) |
| Jun 2006 | - | $133.60K(+90.3%) |
| Mar 2006 | - | $70.20K(-77.4%) |
| Dec 2005 | $310.60K(-73.5%) | $310.60K(+22.2%) |
| Sep 2005 | - | $254.10K(-33.0%) |
| Jun 2005 | - | $379.50K(+575.3%) |
| Mar 2005 | - | $56.20K(-95.2%) |
| Dec 2004 | $1.17M(-87.2%) | $1.17M(-94.3%) |
| Sep 2004 | - | $20.58M(-10.4%) |
| Jun 2004 | - | $22.97M(+178.0%) |
| Mar 2004 | - | $8.26M(-9.5%) |
| Dec 2003 | $9.13M(+87.0%) | $9.13M(-12.1%) |
| Sep 2003 | - | $10.40M(+345.2%) |
| Jun 2003 | - | $2.33M(-31.6%) |
| Mar 2003 | - | $3.41M(-30.1%) |
| Dec 2002 | $4.88M(+8.5%) | $4.88M(-7.1%) |
| Sep 2002 | - | $5.26M(+208.5%) |
| Jun 2002 | - | $1.70M(-46.1%) |
| Mar 2002 | - | $3.16M(-29.8%) |
| Dec 2001 | $4.50M(+72.4%) | $4.50M(-24.7%) |
| Sep 2001 | - | $5.98M(+25.0%) |
| Jun 2001 | - | $4.78M(-8.4%) |
| Mar 2001 | - | $5.22M(+99.9%) |
| Dec 2000 | $2.61M(-50.5%) | $2.61M(-19.3%) |
| Sep 2000 | - | $3.23M(-3.9%) |
| Jun 2000 | - | $3.37M(-30.1%) |
| Mar 2000 | - | $4.81M |
| Dec 1999 | $5.27M(+85.6%) | - |
| Dec 1998 | $2.84M | - |
FAQ
- What is ANI Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is ANI Pharmaceuticals quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
What is ANI Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of ANIP is $144.86M
What is the all time high annual cash & cash equivalents for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual cash & cash equivalents is $221.12M
What is ANI Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, ANIP annual cash & cash equivalents has changed by -$76.26M (-34.49%)
What is ANI Pharmaceuticals quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ANIP is $149.80M
What is the all time high quarterly cash & cash equivalents for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly cash & cash equivalents is $240.11M
What is ANI Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
Over the past year, ANIP quarterly cash & cash equivalents has changed by -$78.80M (-34.47%)